A Hong Kong study of 121,492 older adults links nitrogen-containing bisphosphonates for osteoporosis to a 16% lower Alzheimer ...
Researchers at the University of Hong Kong analyzed electronic medical records from more than 120,000 people age 60 and older. NBP users had a 16% lower risk of developing Alzheimer’s disease and ...
Canada’s Drug Agency is recommending that a second disease-modifying medication used to treat people with early Alzheimer’s disease should be publicly covered, with conditions.
Add Yahoo as a preferred source to see more of our stories on Google. A new drug could halt the progression of Alzheimer's disease. Trials suggest the treatment, called trontinemab, could be the most ...
A breakthrough Alzheimer’s drug will be shipped from Britain around the world while the NHS denies its patients access to it.
Researchers are exploring common medications for conditions such as high blood pressure and diabetes for their potential ...
Dublin, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The "United States Alzheimer Drugs Market to Reach US$ 4.47 Billion by 2033 - 7.78% CAGR Fueled by Drug Innovation and Early Diagnosis" report has been added ...
Share on Pinterest The Alzheimer’s disease drug Leqembi may soon get a new dosing schedule. Eclipse Images/Getty Images An Alzheimer’s disease drug may soon have a new dosing schedule. The medication, ...
If you're someone who is at high risk of developing dementia or Alzheimer's disease, it can be pretty emotionally and mentally draining, especially if you feel like there's very little you can do to ...
The journey to finding an effective treatment for Alzheimer’s disease seems to have hit another dead end. The latest casualty: medications designed to tackle the viral illness herpes. Researchers at ...
An existing drug for HIV could double as a preventative therapy for Alzheimer’s disease, according to researchers. NRTIs (nucleoside reverse transcriptase inhibitors) are antivirals that are approved ...
4don MSN
Donation, support of administration, keep Alzheimer’s drug crusade alive at University of Utah
Neuroscientist Dr. Donna Cross is behind the promising research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results